VIENNA — The highly selective oral Janus kinase (JAK) inhibitor SHR0302 (ivarmacitinib) enables more patients with active rheumatoid arthritis to meet American College of Rheumatology (ACR) response ...
Please provide your email address to receive an email when new articles are posted on . GLP-1 receptor agonists may significantly reduce the risk for cardiovascular events in patients with rheumatoid ...
BL, baseline a Total anemia response = transfusion independence (TI) in pts with BL Hb<10 g/dl with Hb increase ≥ 2g/dl + TI in those who were transfusion-dependent at BL. This is an ASCO Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results